2162 fundamentals
An in-depth look to KEYMED BIOSCIENCES INC operating, investing, and financing activities
2162 free cash flow for H2 23 is -401.19 M HKD. For 2023, 2162 free cash flow was -672.26 M HKD and operating cash flow was -254.03 M HKD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM